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Abstract
Background: Our research group has previously shown that low bone mineral 
density (BMD) is common in children and adolescents with inflammatory bowel 
disease (IBD). However, there is limited knowledge on the development of BMD 
and body composition traits (skeletal muscle and body fat) in early adulthood in this 
patient group.
Objective: The main objective of this thesis was to gain additional understanding of 
BMD and body composition in young adults with childhood-onset IBD.
Method: We performed a follow-up in young adulthood in 74 patients with 
childhood-onset IBD. Bone mineral density, skeletal muscle index (SMI), and 
fat percentage (fat %) were measured with dual X-ray absorptiometry. Body 
composition profiles were defined based on SMI and fat % Z-scores: i) normal, 
ii) obese, iii) myopenic, iv) myopenic-obese. Bone geometry and microstructures 
were estimated with high-resolution peripheral quantitative computed tomography. 
Physical exercise during the previous year was registered. Results were compared to 
normative control cohorts from nearby regions. 
Results: Young adults, especially men with childhood-onset IBD, are at risk 
for low areal BMD and those young men also show widespread deficits in bone 
microstructures. Young adults with childhood-onset IBD have a risk for altered 
body composition traits with an overrepresentation of abnormal body composition 
profiles (myopenic, obese, and myopenic-obese) compared to controls. Young 
men with Crohn’s disease have an especially high risk for myopenia. Despite the 
detrimental effects of having childhood-onset IBD, we found that high levels of 
regular physical exercise in young adulthood are associated with normal BMD and 
body composition traits.
Conclusion: Young adult patients with childhood-onset IBD are at risk for 
disturbances in BMD and body composition.




Bakgrund: Vår forskningsgrupp har tidigare rapporterat att det är vanligt med låg 
bentäthet hos barn och ungdomar med inflammatorisk tarmsjukdom (IBD). Det 
finns dock begränsad kunskap om bentäthet samt kroppssammansättning (muskel 
och fett) hos patientgruppen i ung vuxenålder. 
Mål: Huvudmålet med denna avhandling var att öka kunskapen om bentäthet och 
kroppssammansättning hos unga vuxna med pediatrisk IBD.
Metoder: Vi genomförde en uppföljning av 74 unga vuxna med pediatrisk IBD. 
Bentäthet liksom skelettmuskel index (SMI) och fettprocent (fett %) mättes med 
dual X-ray absorptiometri. Utifrån SMI och fett % Z-score definierade vi fyra 
kroppssammansättnings profiler: i) normal, ii) obese (hög fett %), iii) myopenic 
(lågt SMI), iv) myopenic-obese (både lågt SMI och hög fett %). Bengeometri 
och benmikrostrukturer analyserades med hög-resolution peripheral quantitative 
computed tomography. Patienternas fysiska träningsvanor senaste året registrerades. 
Resultaten jämfördes med normativa kontroller från närliggande regioner. 
Resultat: Unga vuxna patienter, speciellt män, med pediatrisk IBD löper risk för låg 
bentäthet. Vidare har dessa unga vuxna utbredda förändringar i benmikrostrukturer. 
Stor andel av de unga vuxna patienterna har även en störd kroppssammansättning 
med överrepresentation av avvikande profiler (myopenic, obese och myopenic-
obese) jämfört med kontroller. Unga män med Crohns sjukdom löper störst risk 
för myopeni. Regelbunden fysisk träning verkar dock kompensera för den IBD-
associerade risken för låg bentäthet och avvikelser i kroppssammansättning. 
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Inflammatory bowel disease (IBD) is a group of diseases that entails chronic 
inflammation in different parts of the gastrointestinal tract. The prevalence of IBD 
in Sweden is among the highest globally, affecting about 1/150 people1. Almost a 
quarter of patients receive their diagnosis in childhood2, making IBD one of the 
most common chronic childhood illnesses in the western world3. The prevalence 
of childhood-onset IBD in Sweden is elevated as well, and the incidence rises both 
in Sweden and globally4, 5. It is well known that children with IBD are at risk of 
disturbances of growth due to multiple factors related to the disease6. During this 
growth phase in childhood, the body composition changes and the majority of bone 
development occurs7-9. Our research group has previously shown that children with 
IBD run an increased risk to have low bone mineral density (BMD)10, 11. However, 
there is limited knowledge on the development of bone mineralization and body 
composition traits from adolescence to early adulthood in this patient group.
1.1 Inflammatory bowel disease
1.1.1 Clinical characteristics
Patients with IBD, both children and adults, suffer from chronic, relapsing 
inflammation in different parts of the gastrointestinal channel, depending on the 
disease subcategory. The main subcategories are ulcerative colitis and Crohn’s 
disease, and a minority of patients with IBD fall into an unclassified category 
(IBD-U)12. The disease often progresses slowly for weeks to months before a 
diagnosis is established, but a more acute disease progression is also seen in some 
patients. It is challenging to differentiate between ulcerative colitis and Crohn’s 
disease on clinical symptoms only (Figure 1). Diarrhea and abdominal pain are 
dominant symptoms in both disease subcategories. Bloody stools are more common 
in ulcerative colitis, whereas in Crohn’s disease, low-grade fever, weight loss, 
and perianal disease are more frequent12. Delayed puberty and growth retardation 
are typical clinical features in pediatric patients with Crohn’s disease and may 
be the only symptoms in some patients. The clinical picture of IBD is dependent 
on various factors, such as subcategory, the extension of disease, and intensity of 
inflammation12. 
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Figure 1. Clinical symptoms and signs at diagnosis in patients with childhood-onset IBD. 
 
1.1.2 Diagnosis
Diagnosis of IBD is based on clinical, endoscopic, histological, and radiological 
findings and the exclusion of other differential diagnoses, mainly infectious colitis12.
In patients with ulcerative colitis, inflammation is most intense in the rectum 
and can extend throughout the colon (Figure 2). The inflammation is continuous 
and confined to the gastrointestinal wall’s superficial mucosal layer. In contrast, 
patients with Crohn’s disease can have segmental inflammation in any part of the 
gastrointestinal tract (Figure 2). In Crohn’s disease, all gastrointestinal wall layers 
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Figure 2. The extent of inflammation in patients with childhood-onset IBD.
1.1.3 Disease phenotype
In children with IBD, both ulcerative colitis and Crohn’s disease are classified 
according to the phenotype with the Paris classification13, including age at diagnosis, 
the extent of inflammation, growth restriction. Further, in Crohn’s disease, the 
presence of perianal disease is included and the disease behavior is defined as 
inflammatory, stricturing, or penetrating. The Paris classification is a modified 
version of the Montreal classification14 of IBD used in the adult population.
1.1.4 Epidemiology and etiology
IBD can manifest in children of all ages, however, most cases debut usually after 
ten years of age15. Sweden has one of the highest prevalence numbers of childhood-
onset IBD globally; 75/100.000 children were reported to have IBD in 2010, around 
1500 children in total16. The prevalence of ulcerative colitis and Crohn’s disease in 
children is similar in Sweden (30/100.000 and 29/100.000 respectively), with some 
indication that the incidence of Crohn’s disease is on the rise5, whereas IBD-U is 
less common (16/100.000)16. 
The cause of IBD remains unknown, but current research on the pathogenesis 
focuses on four main areas: the gut and systemic immune system, environmental 
triggers, the microbiome, and genetics17.
1.1.5 Treatment and disease activity
Treatment of childhood-onset IBD in Sweden is based on national guidelines18, 
which in turn follow European guidelines19.
Treatment options include nutritional, pharmaceutical, and surgical treatment. All 
patients should also receive lifestyle advice (i.e., smoking cessation and physical 
activity) and psychological support as needed (Figure 3). The treatment goal for 
each patient is to achieve remission of both subjective (symptoms) and objective 
(i.e., laboratory parameters and endoscopy) signs of the disease, without any 
severe side effects or negative impact of therapies on quality of life18. In pediatric 
patients, other important treatment goals are to achieve normal growth, pubertal 
development, and optimal bone health19. 
Ulcerative colitis Crohn´s disease
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Figure 3. Treatment options in patients with childhood-onset IBD. 5-ASA, 5-aminosalicylic acid; 
TNF, Tumor necrosis factor. *in patients with Crohn’s disease
Clinicians use validated disease activity indices to assess disease activity and the 
need for acute medical or surgical intervention at a certain time point. In childhood, 
the Pediatric Ulcerative Colitis Activity Index20 (PUCAI) and Pediatric Crohn’s 
Disease Activity Index21 (PCDAI) are mainly used. In adulthood, several activity 
indices exist22, i.e., the MAYO score23 for ulcerative colitis and Crohn’s Disease 
Activity Index (CDAI)24. However, estimating inflammatory activity over a long 
time, such as during a patient’s whole disease course, is challenging25. To date, there 
is no consensus on how to estimate and describe disease course severity over time 
reliably.
1.1.6 Complications of IBD
Patients with IBD have both long-standing chronic local enteric inflammation and 
systemic inflammation. Disease-associated complications include, e.g., growth 
retardation in pediatric patients26, iron deficiency, and decreased BMD11.
Patients with IBD can also develop several extraintestinal manifestations that 
sometimes are unrelated to the degree of intestinal inflammation, for example, joint 
pain and arthritis, eye disease (uveitis), skin disease (erythema nodosum), liver 
diseases (primary sclerosing cholangitis, autoimmune hepatitis), inflammation in the 
oral cavity (orofacial granulomatosis), and skeletal inflammation (chronic recurrent 
multifocal osteomyelitis)27.
1.1.7 Unique aspects of childhood-onset IBD
The manifestation of IBD at a young age results in a long disease duration with 
subsequent increased risk for complications and specifically in patients with 
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inflammation at diagnosis is often greater in children with IBD than adults. Children 
with ulcerative colitis have more often inflammation in the entire colon and in 
patients with Crohn’s disease, a colonic engagement is more often reported in 
children than adults28, 29.
When IBD affects children during puberty, a crucial period for the growth and 
development of bones and body composition7-9, there are several risk factors for 
BMD and body composition development disturbances. These include, i.e., lack of 
physical exercise, chronic inflammation, nutrition problems, and pharmaceutical side 
effects30, 31. There is, however, limited knowledge on how childhood-onset IBD per 
se may influence BMD32 and body composition development33 into early adulthood, a 
time when peak bone mass (PBM) should have been achieved.
 
1.2 Bone structure, physiology, and assessment of bone 
mineral density
1.2.1 Bone structure
The skeleton divides into the axial and appendicular skeleton. The axial part (head, 
vertebrae, and rib cage) defends some of the vital organs (brain, spinal cord, heart, 
and lungs). In contrast, the appendicular part makes up the limbs and serves as 
attachment sites for tendons and muscles, enabling body movement.
The skeleton comprises long bones (i.e., femur, tibia, and humerus) and flat bones 
(skull, ileum, and scapula). Its primary function is mechanical, but it also stores 
calcium and phosphate, has immunological and endocrine functions, and is home to 
hematopoiesis.
Bones consist of an outer layer, periosteum, a thin membrane that overlies the 
cortical bone, which surrounds the trabecular bone and the medullary cavity 
(Figure 4). Cortical bone is mainly found in the shaft of long bones and the surface 
of flat bones. The osteons in the cortical bone have a dense structure, concentrically 
laid down around central canals known as Haversian canals (Figure 4). Around 
the canal containing blood vessels, nerves, lymphatics, and connective tissue 
are concentric layers of bone matrix (lamellae). There are tiny spaces (lacunae) 
containing osteocytes between the lamellae layers (Figure 4).
Trabecular bone is less compact, lighter, and has an irregular structure. It is most 
abundant in flat bones and the ends of long bones. The trabecular bone has a 
honeycomb-like appearance (Figure 4) made from lamellae forming trabeculae 
(plates and bars) aligned to support stress from external compression. Thicker and 
more numerous trabeculae result in a more robust structure. The trabecular bone’s 
resistance to compressive forces is why it is predominant in the vertebrae.




Figure 4. Cortical and trabecular bone microstructures.
1.2.2 Bone remodeling
Bone tissue undergoes constant remodeling to maintain stability and integrity34. 
Three cell types comprise the basic multicellular unit of the bone and act in a 
coordinated manner: i) osteoblasts (4–6% of bone cells), are responsible for new 
bone formation, ii) osteocytes (90–95% of bone cells), make up the majority of bone 
structure and bone mass, and osteoclasts (1–2% of bone cells), have a role in bone 
resorption35. The bone turnover process in adults is in equilibrium between bone 
formation and bone resorption. The activation of this process results in endosteal 
surface (outside the bone surface) absorption by osteoclasts, attracting osteoblasts 
that form osteocytes and osteoid that calcifies to thicken and strengthen the bone 
during an approximately three to six months process. The rate of bone turnover 
is highest in sites where trabecular bone predominates, such as the vertebrae, and 
lowest at sites with a high proportion of cortical bone, i.e., the hip36.
1.2.3 Regulating factors of bone turnover
The bone turnover process is regulated by both mechanical and biochemical factors, 
including receptor activator of nuclear factor kappa-B ligand (RANKL), receptor 
activator of nuclear factor kappa-B (RANK), and osteoprotegerin (OPG)37. The 
RANKL-RANK-OPG system’s discovery changed the understanding of bone 
homeostasis and osteoimmunity. The RANK receptor located on osteoclast precursor 
cells and mature osteoclasts is activated by RANKL, inducing osteoclast proliferation 
and bone resorption. Osteoblasts secrete RANKL to stimulate bone resorption and 
OPG that inhibits RANKL from binding to RANK and, by that, decreases bone 
resorption. The balance between RANKL and OPG regulates osteoclast activity and 
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is influenced by multiple factors, i.e., mechanical loading, inflammatory cytokines, 
and hormones37. By affecting this system, activated T and B cells, TNF-alpha and 
corticosteroids can increase osteoclast activity and bone resorption36. Thus, patients 
with IBD who suffer from local as well as systemic inflammation are especially at 
risk.
Bone health can be defined as a state in which the skeleton serves its purpose, i.e., 
provides adequate mobility, protects against injury, stores minerals, and executes 
hormonal as well as endocrinological functions38. Many factors influence the bone 
mass accumulation and contribute to bone health. Of those, IBD is associated with 
several of the modifiable factors that influence BMD directly as well as through their 
effects on body composition traits (skeletal muscle and body fat) (Figure 5). These 
are inflammation per se, physical exercise, nutrition, corticosteroids, and other/
unknown factors39-41. Childhood-onset IBD can affect height development, which can 
influence BMD directly or through the body composition traits. Also, several non-
modifiable factors (genetics, age, and gender42, 43) influence BMD directly as well as 
through their effect on height and body composition traits. Notably, genetic factors 




Figure 5. Inflammatory bowel disease is associated with several factors that possibly influence 
BMD directly as well as through their effects on height and body composition traits (skeletal 
muscle and body fat). Genetics, age, and gender are non-modifiable factors associated with BMD, 
height, and body composition traits.
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1.2.4 Bone mineralization in childhood and peak bone mass
In adulthood, the bone turnover process described above maintains the bones’ 
stability and strength. However, in childhood, bone formation dominates as the 
child is growing and the majority of bone mass (around 40%) accumulates during 
puberty7. Factors contributing to optimal bone mineralization such as regular 
physical exercise41, adequate nutrition45, and absence of inflammation31 need to be 
present during this period. They are crucial for bone development and achievement 
of the genetically determined maximum PBM in young adulthood. According to 
Baxter-Jones et al., PBM is achieved in the lumbar spine and total hip, regardless of 
gender, about five years after the individual’s peak height velocity (PHV) and in the 
total body about seven years after PHV7, 46. After attaining PBM in early adulthood, 
BMD gradually declines with age47 (Figure 6). Peak bone mass is one of the most 
important factors influencing fracture risk later in life48. The age-related decline 
in BMD can lead to osteoporosis, especially in older women, as BMD decreases 
more rapidly after menopause (Figure 6). Osteoporosis is defined by the WHO as 
areal BMD (aBMD) value below -2.5 SD from the young adult mean (T-score)49. 
However, the use of T-score is limited to adults over 50 years of age. Thus in children 
and younger adults, aBMD measurements are often based on age- and gender-
matched controls and presented as aBMD Z-score50.
Figure 6. Development of BMD over time. The majority of BMD accumulates during childhood 
and adolescence and reaches PBM in young adulthood. After that, age-related loss of BMD ensues. 
This process accelerates in women after menopause. 
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1.2.5 Bone mineral density measurements
The golden standard for measuring BMD in the clinical setting is dual x-ray 
absorptiometry (DXA)51. This technique uses two x-ray beams of different energy 
levels to differentiate between bone and soft tissue. The low-energy beams attenuate 
more while passing through bone than through soft tissue, whereas the high-energy 
beams are equally attenuated regardless of tissue type. Based on the differences in 
attenuation, estimations of areal BMD (aBMD) will then be calculated in grams of 
bone per cm2 for the whole body and at specific sites of the skeleton (i.e., lumbar 
spine, hip).
The machine software provides values for aBMD, bone mineral content, and bone 
area. Further, it calculates Z-scores of aBMD for children and adolescents compared 
to age- and gender-appropriate normative references. DXA is mainly used in clinical 
practice to diagnose bone fragility and estimate fracture risk in adult patients. 
However, research interest in BMD development during childhood and adolescence 
has increased, especially in patients with chronic inflammatory diseases, as low 
BMD and even osteoporosis in early adulthood could have severe consequences in 
late adulthood as bone health deteriorates with age52.
While DXA has advantages such as widespread availability, high precision, and 
a low dose of radiation (5–10 µSv)53, one important limitation of DXA is that it 
is only two-dimensional. Therefore, additional aspects of BMD such as three-
dimensional volumetric BMD (vBMD), bone geometry, and microstructures need 
to be investigated with more advanced techniques. Bone geometry and vBMD can 
be investigated with peripheral quantitative computed tomography (pQCT). In order 
to assess bone microstructures and architecture, such as thickness and separation 
of the trabeculae, high-resolution pQCT (HR-pQCT) is used. This microstructure 
is the foundation of bone strength54. In contrast to the DXA method, these pQCT 
techniques are primarily used in research and not in a clinical setting yet.
 
1.3 Bone mineral density in patients with inflammatory 
bowel disease
Studies of BMD in patients with IBD are primarily conducted with DXA, resulting in 
aBMD measurements. Several studies in children, but none in adulthood, have been 
conducted using pQCT reporting vBMD measurements and bone geometry55-59. To 
our knowledge, only two studies have been published using HR-pQCT60, 61, one in a 
group of adolescent and adult patients and the other in middle-aged patients.
Children and adolescents with IBD have an increased risk of low aBMD10, 11, 62, 63. 
Our research group and others have previously shown that almost 50% of children 
and adolescents with IBD have aBMD Z-scores lower than -1 and 25% lower than 
-2, without apparent gender differences10, 11, 62, 64, 65. Several studies have reported 
lower aBMD in children with Crohn’s disease than those with ulcerative colitis64, 66, 
whereas other studies found no difference11, 63.
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Adult patients with IBD have also an increased risk of low aBMD67, 68. Two recent 
studies found lower aBMD in middle-aged male patients compared to female 
patients69, 70. In most reports, no difference in aBMD is found between patients with 
Crohn’s disease and those with ulcerative colitis67, 69, but a few studies have reported 
lower aBMD in patients with Crohn’s disease68, 71.
Only one study has, to our knowledge, investigated the development of aBMD 
prospectively from childhood to adulthood33. In this study from Laakso et al., adults 
with childhood-onset IBD were reported to have low aBMD Z-scores at follow-up in 
early adulthood without improving aBMD Z-scores since childhood. In accordance, 
a retrospective study found that young adults with childhood-onset IBD who had 
conducted a DXA scan in young adulthood showed aBMD Z-scores lower than -1 in 
around 50% of cases32. Thus, despite limited data in young adulthood, low aBMD in 
childhood appears to persist into early adulthood without substantial improvements. 
However, Schmidt et al. from our research group reported that patients in late 
adolescence (17 to 19 years of age) had improved their aBMD Z-scores in the lumbar 
spine at first follow-up after two years11. Our research group concluded that there 
might be evidence that patients potentially could improve their BMD by the time 
they reached early adulthood. This finding raised the question of whether young 
adults with childhood-onset IBD could continue to increase their aBMD beyond the 
expected age for attaining PBM.
By using the three-dimensional measurement method pQCT, several studies have 
found trabecular vBMD as well as cortical vBMD55, 58, 59 to be consistently low in 
children with IBD55-59. Interestingly, Werkstetter and colleagues found cortical vBMD 
to be high at diagnosis of IBD56 with normalization after 12 weeks of IBD treatment 
and after reaching remission57.
Further examination of the bone microstructures, utilizing HR-pQCT in adolescents 
and young adult patients with IBD (aged 12–33 years), some of them with 
childhood-onset IBD, revealed deficits in trabecular thickness and larger separation 
of trabeculae but no deficits in cortical thickness or density60. In contrast, in a group 
of older adults with IBD (median age 44 years), both cortical thickness and density 
were affected, but trabecular microstructures appeared to be intact61.
 
1.4 Body composition
Body composition describes the proportions of fat mass and fat-free mass of an 
individual. Fat-free mass is all soft tissue except fat mass and is synonymous 
with lean mass. As with bone mass development, the majority of both lean mass 
and fat mass are acquired in adolescence72. The optimal analysis method of body 
composition depends on localization. A two-component method using DXA is widely 
used, measuring fat mass and lean mass. However, multicomponent models that 
divide body composition into fat, water, protein, and mineral are more accurate for 
measuring the composition of the total body73. The fat mass component is reliably 
estimated with DXA and should be adjusted for body size either for height as a fat 
mass index or for total body weight as percentage fat mass (fat %)73.
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Dual-X-ray absorptiometry can measure lean mass as a useful surrogate marker for 
skeletal muscle74. However, lean mass is not only skeletal muscle but also other 
soft tissue and water. Thus, skeletal muscle mass estimation is most reliable in the 
appendices where the lean mass is primarily skeletal muscle mass, tendons, and 
ligaments75. Further, for increased accuracy of skeletal muscle mass estimations with 
DXA, Baumgartner et al.76 developed the appendicular skeletal muscle mass index 
(SMI). It is attained by dividing appendicular lean mass by height squared (lean mass 
in arms and legs [kg]/height [cm]2).
In healthy individuals, body composition components and BMD measurements 
correlate with each other. The skeletal muscle affects bone tissue directly and there 
is a strong correlation between SMI and BMD77. In contrast, fat mass and, thus, 
increased weight are associated with higher BMD, although to a lesser extent than 
SMI78. Further, Baumgartner et al.79 proposed that SMI and fat mass should be 
interpreted simultaneously in the elderly by defining four specific body composition 
profiles: normal profile, sarcopenic profile (low skeletal muscle mass), obese profile 
(high fat mass), and sarcopenic-obese profile (a combination of both low skeletal 
muscle mass and high fat mass). However, in recent years, a consensus has been 
reached that sarcopenia is defined by both lack of skeletal muscle mass (myopenia) 
and muscle function80. Thus, in this thesis, the term ´myopenia´ is used for lack of 
skeletal muscle mass when there is no data on muscle function. 
1.4.1 Body composition in IBD
Body composition has been studied only to a limited extent in children with IBD. 
Total body lean mass deficits seem to be common81-83, but there are conflicting 
reports on how fat mass is affected81-83. After the publication of study II in this thesis, 
one study reported SMI in children with IBD, highlighting deficits of skeletal muscle 
mass84.
Body composition has been more widely studied in adults with IBD, although with 
divergent results. A recent review85 summarized seventeen studies that reported data 
from adult patients with Crohn´s disease. Lean mass deficits were reported in 28% of 
patients and fat mass was low in 31%. Eight studies reported data from adult patients 
with ulcerative colitis; a reduction in lean mass was found in 13% of patients, fat 
mass was reduced in 13%, and increased in 12% of patients compared to controls. It 
appears that the male gender was more often found to be a risk factor for alterations 
in body composition components85, especially in patients with Crohn’s disease86.
Two studies have focused on SMI and its association to BMD in adult patients with 
IBD. One focused on patients with Crohn’s disease, finding a high prevalence of 
myopenia associated with low aBMD87. The other found myopenia to be prevalent 
(21%), regardless of disease subcategory or gender, and that low SMI predicted 
low aBMD. A strong association has been found in pQCT studies between variables 
indicating low skeletal muscle mass and deficits in trabecular and/or cortical 
vBMD55-59.
Young adults with childhood-onset inflammatory bowel disease  
24 25
Body composition reflects the balance of physiological and, in chronic diseases such 
as IBD, pathophysiological processes. Patients with IBD have several risk factors 
that can affect this balance, such as nutritional problems88, inflammation per se89, 90, 
lack of physical exercise91, and corticosteroid side effects92, and which potentially 
manifest as altered body composition (Figure 5). These risk factors resemble those 
known for low BMD. 
In this context, it has to be noted that body mass index (BMI) as an estimation of 
body composition in patients with IBD has proved to be unreliable85, 93. Thus, more 
accurate methods are needed and DXA is the most widely available method.
 
1.5 Physical exercise in IBD
The terms ’physical exercise’ and ’physical activity’ are often used interchangeably. 
However, physical activity is considered any movement by skeletal muscles resulting 
in energy expenditure measured in kilocalories. It can be categorized into different 
activities such as sports, occupational, household, and other activities. Physical 
exercise is a physical activity category. It is a planned, structured, and regular activity 
to improve or maintain physical fitness94.
Children with IBD are reported to be less physically active than age-matched healthy 
controls95. As regular physical exercise in childhood promotes healthy exercise habits 
in early adulthood, this could lead to less physical exercise in adulthood96. However, 
to the best of our knowledge, there are no data available regarding this in young 
adults with childhood-onset IBD.
Physical exercise habits in adults with IBD have also been studied. Tew et al. 
reported that less than one-fifth of adults with IBD were engaged in a high amount of 
regular physical exercise and one-third was more or less sedentary97. In comparison, 
a study on physical exercise habits in healthy adults from Sweden reported higher 
physical activity levels, where two-fifths of adults were heavily engaged in physical 
exercise98.
Physical exercise plays a vital role in developing and maintaining bone health and 
body composition. The importance of skeletal muscle activity is well-documented 
in healthy individuals99-101. The relationships between physical exercise, BMD, lean 
mass, and fat mass in patients with IBD have only been studied to a limited extent; 
no data are available in young adults with childhood-onset IBD. Of the studies in 
both children and adult patients with IBD102, 103, physical exercise appears to be 





The main objective of this thesis was to gain additional understanding of bone  
health and body composition in young adults with childhood-onset IBD.
2.2 Specific aims
I. This study aimed to investigate whether young adults with childhood-onset  
 IBD have compromised bone mineralization and to correlate their BMD  
 data to anthropological measures and disease subcategories. A secondary  
 aim was to examine whether patients with childhood-onset IBD have the  
 potential to improve their BMD into young adulthood beyond the expected  
 age for attaining PBM, as our previous data have indicated.
II. This study aimed to investigate body composition with the focus on SMI and  
 fat % in young adults with childhood-onset IBD. A secondary aim was to  
 evaluate to which extent BMD and body composition traits relate to each  
 other. 
III. This study aimed to investigate the amount of physical exercise undertaken  
 by young adults with childhood-onset IBD and its associations to BMD,  
 SMI, and fat %. A secondary aim was to evaluate whether there is a link,  
 at the individual level, between physical exercise habits in adolescence and  
 later in early adulthood.
IV. This study aimed to investigate the extent of microstructural alterations  
 in young adult males with IBD and the association between these changes  
 and the patient’s SMI and the amount of physical exercise.
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3 Patients and methods
3.1 Patients
This thesis is a part of a longitudinal study conducted by our research group. The 
current thesis is primarily based on the data from the second follow-up in young 
adulthood. A total of 166 patients were initially identified from the only two centers 
in the catchment area responsible for the diagnosis, treatment, and follow-up of 
childhood-onset IBD and were invited to participate in our longitudinal study. As 
a result, the recruited patient population included individuals with mild, moderate, 
and severe disease, representing the entire clinical spectrum of childhood-onset 
IBD. These two centers are The Queen Silvia Children’s Hospital at Sahlgrenska 
University Hospital, Gothenburg, and the Department of Pediatrics at Södra 
Älvsborgs Hospital, Borås.
In total, 144 of the 166 initially eligible patients participated in the baseline 
measurement conducted between 2003 and 2005. These baseline aBMD results have 
previously been published by Schmidt et al.10 Of those 144 patients, 126 participated 
in the first follow-up measurement two years later, between 2005 and 2007, of which 
the results were also previously published by Schmidt et al.11
In this current second follow-up, DXA measurements for BMD and the body 
composition of 74 young adult patients with IBD were carried out between 2012 and 
2015. Thus, a total of 52 out of 126 patients at the first follow-up did not participate 
in the second follow-up. Patients who did not participate had relocated out of the 
area, declined to participate, or we failed to establish contact. These non-participants 
(n=52) did not differ significantly regarding clinical characteristics from the 





Study I included all patients that participated in the described second follow-up. 
Study II included all patients that had reached 18 years of age at any study visit and 
not only the second follow-up. Study III included all patients that participated in 
the second follow-up and answered the physical exercise questionnaire. Study IV 
included all male patients at the second follow-up (Table 2).
 
3.3 Control cohorts
We used several control cohorts in this project regarding BMD and body composition 
(Table 2).
3.3.1 Study I - Control cohorts – Bone mineral density data
The GOOD study: This cohort included 1,068 population-based young adult men 
aged 18–25 years from the greater Gothenburg area, Sweden (the GOOD study46, 104).
LUNAR standard references: The normative healthy reference database, which 
uses sex, weight, ethnicity- and age-specific reference data, is provided by the DXA 
manufacturer LUNAR® (GE Medical Systems Lunar).
We used the current Swedish national standards for growth monitoring and 
evaluation as the references for height, weight, and PHV9, 105.
 
Patient characteristics Participants (n=74) Non-participants (n=52) p value
Age (years) 16.7±2.9 17±3.1 0.650
Weight (kg) 60.7±15.6 59.4±16.1 0.643
Height (cm) 168±13.3 170.7±14.5 0.296
Female gender, n (%) 25 (34%) 19 (37%) 0.752
Crohn's disease, n (%) 25 (34%) 13 (25%) 0.287
Age at diagnosis (years) 11.1±3.3 11.2±3.4 0.924
Disease duration (years) 3.4±2.7 3.7±2.9 0.597
Current corticosteroid treatment 7 (10%) 5 (11%) 0.557
Any azathioprine treatment 37 (54%) 22 (46%) 0.235
Total body aBMD Z-score 0.1±1.2 0.2±1.3 0.649
Lumbar spine aBMD Z-score -0.8±1.4 -0.7±1.5 0.658
Table 1. Characteristics of participants and non-participants at the first follow-up, the last 
common study visit
aBMD, Areal bone mineral density. Values are displayed as mean±SD or n (%). Difference 
between groups tested with Student's t -test or Fisher's exact test.
Young adults with childhood-onset inflammatory bowel disease  
28 29
3.3.2 Study II - Control cohorts – Bone mineral density and body 
composition data 
The GOOD study: This cohort included 1,068 population-based young adult men 
aged 18–25 years from the greater Gothenburg area, Sweden (the GOOD study46, 104).
Normative data, Malmö: This cohort entailed normative data collected from 221 
young adults (113 men and 108 women) in the age range of 18–30 years from the 
greater Malmö area, Sweden106.
3.3.3 Study III - Control cohorts – Bone mineral density, body  
composition, and physical exercise data
The GOOD study: This cohort included 1,068 population-based young adult men 
aged 18–25 years from the greater Gothenburg area, Sweden (the GOOD study46, 104).
Normative data, Malmö: This cohort entailed normative data collected from 221 
young adults (113 men and 108 women) in the age range of 18–30 years from the 
greater Malmö area, Sweden106. Of those, 86 had available physical exercise data and 
were included in study III.
Pediatric osteoporosis prevention (POP) study: This cohort consisted of 187 young 
adults (97 men and 90 women) aged 18–25 years from the Malmö region107.
3.3.4 Study IV - Control cohort – HR-pQCT, body composition,  
and physical exercise data
The GOOD study: Each patient was matched by age and height with five controls 
(n=245) from the GOOD study46, 104. 
Study I Study II Study III Study IV
Patients 74 94 72 49
Study visit
All patients at the 
second follow-up
Any study visit Second follow-up Second follow-up















Controls in total 1068 1289 1341 245
GOOD study (n=245, age- 
and height-matched)




We registered the following clinical data: age, gender, height, weight, disease 
subcategory, disease duration, and age at disease-onset. Furthermore, data from 
medical records were obtained regarding pharmacologic treatments received at or 
before the study visit. These included corticosteroids, 5-aminosalicylic acid (5-
ASA), azathioprine, methotrexate, and biological therapy [anti-tumor necrosis factor 
(TNF)-alpha]. No biological therapies other than anti-TNF-alpha were used in these 
patients. Intestinal surgery due to IBD and fistula surgical procedures data were also 
registered.
Height was measured to the nearest 0.5 cm using a wall-mounted stadiometer. 
Weight was measured to the nearest 0.1 kg using a calibrated standard scale with the 
participants in light clothes. The hand’s maximal grip strength (kg) was measured 
at the second follow-up in the majority of patients (n=70) using the Jamar hydraulic 
hand dynamometer (5030J1, Jackson, MI, USA) with an adjustable handgrip.
Detailed growth and weight charts from birth until 18 years of age were available 
for 43 patients, with age at PHV being derived from each growth curve for 
which there was sufficient information on all three growth phases and fitting the 
Infancy-Childhood-Puberty model by minimizing the sum of the squares using a 
modification of the Levenberg-Marquardt algorithm108. For PHV estimation, two or 
more measurements during the critical “peri-PHV” period were needed, not more 
than two years from PHV and not more than three years from each other. PHV is 
generally believed to be reached within two years of pubertal onset105, 108. According 
to Greulich and Pyle’s method, bone age was estimated at baseline by a radiograph of 
the left wrist, as previously published by our group10.
 
3.5 Bone mineral density
A total of 74 patients participated in all three study visits (baseline, first follow-up, 
and second follow-up), during which they underwent DXA scans for estimation 
of aBMD (g/cm2), bone mineral content (g), and bone area (cm2) in the total body, 
lumbar spine (L1–L4), and total hip. All DXA measurements were performed at 
the Sahlgrenska University Hospital in Gothenburg (Sweden). We used a Lunar 
densitometer (DPX-IQ version 4.7e; GE Medical Systems Lunar, Madison, WI), with 
Lunar software ver. 4.7, for the baseline and first follow-up measurements. The data 
for these measurements have previously been published10, 11. At the second follow-
up, we used the Lunar Prodigy DXA (GE Medical Systems Lunar). The GOOD 
cohort controls were measured with the same Lunar Prodigy DXA apparatus46 
as the patients. The control populations from the Malmö region were measured 
using a Lunar DPX-L (version 1.3z; GE Medical Systems Lunar) apparatus106. 
The correlation of aBMD measurements between the DPX-IQ and Prodigy DXA 
machines is very strong at different measurement sites (R=0.98–0.99)109. The aBMD, 
bone mineral content, and bone area values were expressed as absolute values. Areal 
BMD was also expressed as age- and gender-adjusted Z-score, based on the control 
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population and in the first study, the DXA manufacturer standard reference. The 
aBMD Z-score for total hip could not be calculated at the first follow-up due to the 
manufacturer’s lack of reference data.
 
3.6 HR-pQCT
The bone microstructure was measured non-invasively with HR-pQCT at the 
ultra-distal tibia. The leg ipsilateral to the non-dominant arm of the participant was 
fixated in anatomically formed carbon shells and placed in the HR-pQCT machine 
(XtremeCT; Scanco Medical AG, Brüttisellen, Switzerland). The operator placed a 
reference line at the tibia’s articular plateau, which was identified with an ordinary 
X-ray. Images were taken at a fixed distance (22.5 mm) from the reference line.  
With an isotropic resolution of 82 µm, the device captured 104 parallel images and 
depicted a 9.02 mm 3D representation of the bone (Figure 7). 
 
Figure 7. Representative image from our HR-pQCT scan at the tibia, showing cortical and 
trabecular microstructures. 
Images were obtained in approximately three minutes, and the effective dose 
generated was 3 µSv per measurement. Measurements were repeated until quality 
was sufficient. A contour was automatically placed around the bone to separate the 
periosteal surface from the surrounding extra-osseous soft tissue. This contour could 
be adjusted by the operator when needed. The standard analysis was performed 
according to an earlier described protocol110. From the measurements the following 
parameters were obtained: volumetric density (mg/cm3), cortical cross-sectional 
area (mm2), cortical volumetric BMD (mg/cm3), cortical thickness (mm), periosteal 
circumference (mm), trabecular cross-sectional area (mm2), trabecular bone volume 
fraction (%), trabecular number (mm-1), trabecular thickness (mm), and trabecular 
separation (mm). The two same operators performed all measurements and graded 




Lean soft tissue mass of the total body, arms, and legs (kg), as well as total body fat 
mass (kg), were measured with DXA using a Lunar densitometer (DPX-IQ version 
4.7e; GE Medical Systems Lunar, Madison, WI). The GOOD cohort controls were 
measured with the same Lunar Prodigy DXA apparatus46 as the patients, while the 
control populations from the Malmö region were measured using a Lunar DPX-L 
(version 1.3z; GE Medical Systems Lunar) apparatus106. The correlation of body 
composition measurements using different Lunar machines is strong (R=0.99 for 
lean mass and R=0.99 for fat %)109. Therefore, no adjustments were made to the 
raw measurement data. We calculated SMI as the sum of the arms and legs lean 
soft tissue mass divided by the height squared (kg/m2). Skeletal muscle index is a 
reasonable estimate of the total body skeletal muscle mass77. Fat mass was calculated 
as the fat mass percentage (fat %) of the total body weight73.
 
3.8 Body composition profiles
By taking each patient’s SMI and fat % into account, we modified the theoretical 
model proposed by Baumgartner79, defining four body composition profiles. In our 
modified model, we use the term myopenia for an SMI Z-score <-1 to define low 
skeletal muscle mass, which is in line with Bryant et al.111
The four body composition profiles were defined as follows:  
i) normal: SMI Z-score >-1 and fat % Z-score <1;  
ii) obese: SMI Z-score >-1 and fat % Z-score >1;  
iii) myopenic: SMI Z-score <-1 and fat % Z-score <1;  
iv) myopenic-obese: SMI Z-score <-1 and fat % Z-score >1. 
The cut-off for SMI Z-score of <-1 in the controls corresponded to SMI of 6.1 kg/
m2 for females and 7.5 kg/m2 for males. Obesity was defined as fat % Z-score >1, 
which corresponded to fat % of >39% for females and >27% for males. The cut-offs 
for myopenia in the present study were higher than in the original publication of 
Baumgartner79, where myopenia was defined as SMI Z-score lower than -2, cut-offs 
were SMI of 5.5 kg/m2 for females and 7.26 kg/m2 for males. Cut-offs for fat % were 
similar to Baumgartner79, >38% for females and >27% for males.
 
3.9 Physical exercise
At the second follow-up in early adulthood, we used a standardized physical 
exercise questionnaire to gather physical exercise habits in the last 12 months. 
The questionnaire also included questions regarding participation in sports during 
childhood and adolescence. Physical exercise was defined as regular training, 
whereas activities such as bicycling to work were not considered. Physical exercise 
was registered as the time in hours per week (h/w) spent on training. Seasonality was 
taken into account and the weekly amount of training was averaged for the entire 
year. In this thesis, we use the term “amount of physical exercise” to describe the 
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average amount of training over the past year in hours per week. Corresponding data 
on physical exercise in the control group (n=1,341) were also registered in hours per 
week (h/w) and averaged for the past year.
 
3.10 General statistics
The thesis author performed statistical analyses with SPSS ver. 26 software (IBM 
Corp., Armonk, NY). Continuous variables were presented as median [range or 
interquartile range (IQR)] or mean (SD). Categorical variables were presented 
as n (%). Differences between three or more groups were tested with analysis of 
variance (ANOVA), the Kruskal-Wallis one-way ANOVA, or Extended Fisher’s 
exact test based on variable type and distribution. The differences between any two 
groups were tested with the Mann-Whitney U-test, student’s t-test, or Fisher’s exact 
test based on variable type and distribution. All tests were 2-tailed and conducted, 
assuming a significance level of 0.05.
3.10.1 Study I - Specific statistics
A single sample t-test was used to compare the patient’s standard reference aBMD 
Z-score to the standard reference population mean Z-score of zero. The regression 
models were constructed with a stepwise approach with the total body aBMD 
and lumbar spine aBMD Z-scores as dependent variables. The following primary 
predictors were selected: aBMD Z-score at baseline; gender; weight at second 
follow-up; and the average parental aBMD Z-score (previously published by our 
group44). The following secondary predictors were used for the selection process: 
height Z-score at second follow-up; age at second follow-up; disease subcategory; 
age at diagnosis; been treated with biological agents, azathioprine, 5-ASA or 
corticosteroids; and the difference between bone age and chronologic age (ΔBA-CA) 
at baseline measurement.
The final model included all four primary predictors and three secondary predictors: 
age at diagnosis, previous treatment with biologics, and corticosteroids. The other 
secondary predictors were not significant confounders or predictors and did not 
improve the model.
3.10.2 Study II - Specific statistics
We used measurements in our combined control cohort for SMI, fat %, and aBMD 
in total body, spine, and femoral neck to calculate age- and gender-specific Z-scores. 
Using linear regressions in females and males separately, we calculated age-specific 
expected mean values for SMI, fat %, and aBMD. Using these expected values and 
the measured values for each study participant, we calculated an individual Z-score 
for SMI, fat %, and aBMD, using the following formula: the measured value of the 
participant, minus the expected mean value of controls for the participant’s age, 
divided by the root mean square error of the regression model.
Differences in continuous variables between groups of body composition profiles 
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were tested with an analysis of variance (ANOVA), followed by a Student’s t-test 
in-between groups with Bonferroni correction as a posthoc test, if the ANOVA was 
statistically significant. All correlations between SMI, fat %, and aBMD Z-scores 
were estimated with Spearman’s rank correlation coefficient (r).
We used a multivariable regression model to estimate the association between aBMD 
Z-score (dependent variable) and diagnosis of IBD (covariate 1) and SMI Z-score 
(covariate 2).
3.10.3 Study III - Specific statistics
Age- and gender-specific Z-scores were calculated with the same formula as in 
study II. The multivariable regression models had one aBMD or body composition 
trait Z-score as a dependent variable (total body aBMD, spine aBMD, femoral neck 
aBMD, SMI, or fat %). “Diagnosis of IBD” and “physical exercise subgroup” were 
used as covariates. Additionally, SMI Z-score was added as a covariate for the second 
model with femoral neck aBMD as the dependent variable.
3.10.4 Study IV - Specific statistics
The control cohort of 245 young men was selected from 829 control subjects. We 
used propensity score matching for age and height with an R package plugin for 
SPSS. The patient to control ratio of 1:5 was used for a maximal number of controls 
and minimal variation of the matching variables.
Each multivariable regression model had one HR-pQCT measurement as the 
dependent variable. Three covariates were used as predictors: diagnosis of IBD, SMI, 
and physical exercise subgroup (≥4 hours per week vs. <4 hours per week).
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4 Results
4.1 Study I - BMD in young adults with childhood-onset 
IBD
This study aimed to investigate whether young adults with childhood-onset IBD have 
compromised bone mineralization and to correlate their BMD data to anthropological 
measures and disease subcategories. A secondary aim was to examine whether 
patients with childhood-onset IBD have the potential to improve their BMD into 
young adulthood beyond the expected age for attaining PBM, as our previous 
data have indicated. At the second follow-up in young adulthood, 74 patients with 
childhood-onset IBD participated and were measured with a DXA scan.
4.1.1 Results
A high percentage of the patients with childhood-onset IBD had low aBMD Z-scores 
in the lumbar spine. One third of the patients, 33.8% (n=25), had an aBMD Z-score 
of less than -1 and 9.5% (n=7) had an aBMD Z-score of less than -2. The total body 
and hip aBMD Z-scores were similar to what was expected in the normal population, 
15.6% and 2.2%, for -1 and -2, respectively.
There was a clear gender difference concerning aBMD Z-scores in the patient 
cohort. Young adult male patients had lower mean aBMD Z-score in the total body 
(-0.2±1 SD, p=0.150), lumbar spine (-0.8±1.1 SD, p<0.001), and total hip (-0.5±0.9 
SD, p<0.001) than the LUNAR standard references. Similarly, low aBMD Z-scores 
were observed when male patients were compared to the controls from the GOOD 
study. In contrast, the young adult female patients had similar or slightly higher 
aBMD Z-scores in the total body (0.4±1 SD, p=0.040), lumbar spine (-0.1±1.1 SD, 
p=0.810), and total hip (0.2±0.9 SD, p=0.380) compared to the LUNAR standard 
references. A comparison between male and female patients revealed lower aBMD 
Z-scores in male patients at all three measurement sites (mean difference [95% CI]): 
total body (-0.64, [-1.13 – -0.15]), lumbar spine (-0.75, [-1.29 – -0.21]), and total hip 
(-0.71, [-1.16 – -0.25]).
A gender difference was also observed with regard to height. Male patients with 
IBD in early adulthood were shorter (mean height Z-score -0.38±0.9 SD, p=0.004) 
compared to national references. In contrast, female patients with IBD had a similar 
mean height Z-score of -0.24 (±1.2 SD, p=0.338) compared to national references.
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A total of 17 patients, seven women and ten men, had per definition, reached the 
estimated age for PBM in the lumbar spine and total hip at the baseline study visit or 
the first follow-up when as at least five years had elapsed since peak height velocity. 
Notably, at the second follow-up, we observed significant increases in lumbar spine 
aBMD in this group beyond the expected age for attaining PBM.
The entire group of patients with IBD increased the aBMD Z-score in the lumbar 
spine between the first follow-up (-0.9±1.4 SD) and the current second follow-up 
(-0.6±1.2 SD, p=0.001). No such significant difference was seen for the total body 
aBMD Z-score.
4.1.2 Conclusion
Young adult men with childhood-onset IBD are at risk for compromised aBMD 
Z-scores. However, both male and female patients showed improvements in aBMD 
after being expected to have achieved PBM.
 
4.2 Study II - Body composition in young adults with 
childhood-onset IBD
This study aimed to investigate body composition with the focus on SMI and fat % 
in young adults with childhood-onset IBD. A secondary aim was to evaluate to which 
extent BMD and body composition traits relate to each other.
All patients who had reached the age of 18 years at any study visit (n=94, male 
gender n=64, ulcerative colitis n=65) were included in this analysis. Body 
composition can be divided into two major compartments: muscle and fat. The DXA 
scan measures lean mass, which is in the appendices mainly comprised of skeletal 
muscle. Therefore, we used SMI to represent the muscle compartment. Skeletal 
muscle index is the combined weight of lean mass in arms and legs divided by the 
participant’s height squared (kg/m2), similarly to the calculation of BMI. The DXA 
scan also measures the fat mass and we used the percentage of fat mass (fat %) by 
dividing the total fat mass with the participant’s total weight to represent the fat 
compartment.
Furthermore, based on a theoretical model proposed by Baumgartner et al.79, we 
developed a modified version. We defined four body composition profiles, described 
in greater detail in the chapter 3.8 in the Patients and Methods section. Z-scores for 
SMI and fat % were calculated from a large control cohort and both SMI and fat % 
were taken into account to define the body composition profiles.
4.2.1 Results
In total, 51% of the patients with IBD had a normal body composition profile 
compared to 72% of the controls (p<0.001) (Table 3). A larger proportion of patients 
(33%) had a profile including myopenia (lack of skeletal muscle mass) than the 
controls (17%, p<0.001) (Table 3). Similarly, 25% of the patients had an obese body 
composition profile compared to 14% of the controls (p=0.006) (Table 3). A profile 
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with a combination of myopenia and obesity was observed in 9% of the patients 
compared to 2% of the controls (p=0.002) (Table 3). Patients with myopenia as 
part of their profile were also found to have lower grip strength than those without 
myopenia.
We compared the aBMD Z-scores of patients with a normal body composition 
profile to patients with the other three profiles (obese, myopenic, myopenic-obesity). 
The mean total body aBMD Z-score of patients with the myopenic (-1.3±0.7) and 
myopenic-obese (-1.4±0.9) profile was lower than in patients with a normal body 
composition profile (-0.2±1.1), p<0.001, and p=0.004, respectively. However, the 
mean total body aBMD Z-score in patients with an obese profile (0±1) was similar to 
those with a normal profile (p=0.542).
We observed a strong positive correlation between SMI Z-score and aBMD Z-scores 
when combining all participants into one group. The correlation was significant for 
aBMD Z-scores in the total body (r=0.61, p<0.001), spine (r=0.52, p<0.001) and 
femoral neck (r=0.55, p<0.001). However, there were no significant correlations 
between the fat % Z-score and aBMD Z-scores.
Using multivariable regression analyses and adjusting for SMI Z-score, we found 
that a diagnosis of IBD was independently associated with a lower aBMD Z-score in 
the total body (B, 95% CI) (-0.33, -0.51– -0.15), lumbar spine (-0.51,-0.70 – -0.32) 
and femoral neck (-0.37,-0.58 – -0.16).
4.2.2 Conclusion
The body composition of young adults with childhood-onset IBD deviated from the 
control cohort as body composition profiles including myopenia and obesity were 
more common in the patient group. Despite the strong correlation of SMI Z-scores 
to aBMD Z-scores, the IBD diagnosis per se was independently associated with a 
reduction in aBMD Z-scores.
 
4.3 Study III - Physical exercise in young adults with 
childhood-onset IBD
This study aimed to investigate the amount of physical exercise undertaken by 
young adults with childhood-onset IBD and its associations to BMD, SMI, and fat 
%. A secondary aim was to evaluate whether there is a link, at the individual level, 
between physical exercise habits in adolescence and later in early adulthood. In our 
second follow-up in early adulthood, a total of 72 patients underwent a DXA scan 
and answered a questionnaire regarding physical exercise. A total of 1,341 controls 
combined from three different cohorts were used.
Three subgroups based on the amount of regular physical exercise over the last year 
were defined: 
Subgroup 1: no physical exercise; patients (n=31)/controls (n=428). 
Subgroup 2: less than four hours a week; patients (n=19)/controls (n=428). 




We observed in the patient cohort of young adults with childhood-onset IBD 
somewhat lower participation in physical exercise (around 60%) than in the controls 
(around 70%); however, the difference was not statistically significant (p=0.053). 
The patients who exercised regularly in young adulthood reported higher sports 
participation in late adolescence than those who were sedentary (subgroup 1).
The sedentary patients (subgroup 1) had significantly lower aBMD Z-scores in 
the total body, spine, and femoral neck than the controls in subgroup 1. Patients 
in subgroup 2, who trained less than four hours a week, had similarly low aBMD 
Z-scores in the total body and spine but not in the femoral neck compared to controls 
in subgroup 2. When comparing the patients who trained more than four hours a 
week (subgroup 3) to controls, we found similar aBMD Z-scores in the total body but 
lower Z-scores in the spine and femoral neck. However, when patients in subgroup 
3 were compared to the entire control cohort consisting of the controls for all three 
exercise subgroups, they had similar aBMD Z-scores, close to zero, at all three 
measurement sites. The subgroup of patients who trained regularly tended to have 
higher aBMD Z-scores at the total body and femoral neck than those who were 
sedentary (subgroup 1). However, the difference in aBMD Z-score between the three 
physical exercise subgroups did not reach statistical significance for the total body, 
femoral neck, or spine aBMD Z-scores.
Concerning SMI Z-scores in the different physical exercise subgroups, we found 
that patients in subgroup 1 had a significantly lower SMI Z-score compared to 
subgroups 2 as well as 3. When comparing the SMI Z-score of the three patient 
exercise subgroups separately with that of the entire control cohort (control exercise 
subgroups 1, 2, and 3), only patient exercise subgroup 1 differed in median SMI 
Z-score to the entire subgroup of controls. A higher degree of physical exercise 
was associated with a higher SMI Z-score as the SMI Z-score differed significantly 
between patients in exercise subgroups 1, 2, and 3.
Both patient subgroups 1 and 2 had a higher fat % Z-score than the corresponding 
control exercise subgroups. However, patients in subgroup 3 had a fat % Z-score in 
the same range as the corresponding control exercise subgroup. Furthermore, the 
difference between each patient exercise subgroup (subgroups 1, 2, and 3) was also 
significant. The higher the amount of physical exercise was, the lower was the fat % 
Z-score.
To investigate if a diagnosis of IBD per se was independently associated with 
aBMD Z-score deficits when adjusted for the amount of physical exercise subgroup 
(categorized in three exercise subgroups, of which subgroup 1 constitutes the 
reference group), we performed several multivariable regression analyses. We 
found that suffering from IBD was negatively associated with Z-scores at all aBMD 
measurement sites, regardless of the physical exercise subgroup. Furthermore, 
performing regular physical exercise of four or more hours a week (subgroup 3) 
was independently associated with higher aBMD Z-scores at all sites. Less than 
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four hours of physical exercise a week (exercise subgroup 2) was also associated 
with higher aBMD Z-scores in the total body and femoral neck, albeit not in the 
spine. Furthermore, to analyze whether the association of physical exercise was 
mediated through the effect of skeletal muscles on bone and not the exercise per se, 
an additional regression analysis for the femoral neck was performed. This analysis 
showed that, when comparing subgroup 2 and 3 to subgroup 1, physical exercise was 
independently associated with increased aBMD Z-score in the femoral neck when 
adjusted for SMI Z-score and diagnosis of IBD.
4.3.2 Conclusion
Regular physical exercise participation tended to be lower in young adults with 
childhood-onset IBD compared to controls. Despite the negative relationship of 
having IBD on aBMD and body composition, patients who exercise regularly tended 
to have a positive association with higher aBMD and significantly more muscle mass 
and lower fat mass.
 
4.4 Study IV - Young adult male patients with  
childhood-onset IBD had compromised cortical and  
trabecular bone microstructures
This study aimed to investigate the extent of microstructural alterations in young 
adult males with IBD and the association between these changes and the patient’s 
SMI and the amount of physical exercise. A total of 49 young men from the second 
follow-up in early adulthood were included in this analysis. Each participant was 
scanned with HR-pQCT to measure bone geometry and microstructures. The patients 
were compared to a control group of young men (n=245) selected from the GOOD 
study cohort by propensity score matching for age and height in a 1:5 patient to 
controls ratio.
4.4.1 Results
Analyzing bone geometry parameters, young men with IBD showed a reduction 
of the cortical area compared to controls. However, no significant differences were 
seen in the trabecular or total tibia area. The vBMD, cortical vBMD, and trabecular 
volume fraction were lower in patients than in controls.
Significant differences in microstructures were apparent, as cortical and trabecular 
thickness were lower, and the trabeculae were more separated in patients than in 
controls. Patients with Crohn’s disease had cortical and trabecular bone parameters in 
the same range as those with ulcerative colitis.
We performed multivariable regression analyses with each measured bone parameter 
as a dependent variable. The following three parameters were used as covariates: 
SMI Z-score, physical exercise of four or more hours, and a diagnosis of IBD. We 
found that IBD per se was independently associated with all previously mentioned 
bone parameters, except trabecular separation. Furthermore, SMI Z-score was 
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independently associated with all measured bone parameters, except cortical vBMD. 
Physical exercise of four or more hours was not independently associated with any 
bone parameters.
4.4.2 Conclusion
Young adult men with childhood-onset IBD had deficits in cortical and trabecular 
bone geometry and microstructures compared to age- and height-matched male 
controls.
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5 Discussion
The importance of bone health in patients with IBD has received increasing attention 
in the last decades. The current ECCO/ESPGHAN consensus guidelines19 emphasize 
bone health as a marker of effective therapy and disease control in children with IBD 
and advocate BMD monitoring. They noted that failure to control inflammation with 
consequent compromised bone health could result in an increased risk of fractures 
later in life. However, there is limited data on BMD and body composition in adult 
patients with childhood-onset IBD. 
This thesis aimed to investigate BMD development in patients with childhood-onset 
IBD from childhood into early adulthood. The purpose was also to evaluate body 
composition traits in these young adult patients. Further, we wanted to investigate the 
physical exercise habits in young adults with childhood-onset IBD and these habits' 
association to BMD and body composition traits. 
In summary, we could show in our cohort of young adults with childhood-onset IBD 
that lumbar spine BMD deficits persisted from childhood into young adulthood. 
However, we could also observe some BMD improvements during late adolescence, 
which raises the question as to whether patients with childhood-onset IBD may have 
the potential to increase lumbar spine aBMD beyond the estimated time for PBM. 
We found that young adult male patients were especially at risk for low aBMD and 
had widespread bone microstructural alterations. The body composition traits in 
young adults with childhood-onset IBD were altered as well. A higher proportion of 
patients with IBD had myopenic or myopenic-obesity body composition profiles than 
controls. The profiles, which include low SMI, were associated with decreased BMD. 
Having childhood-onset IBD was independently associated with compromised BMD 
and body composition. However, regular physical exercise in patients with IBD was 
associated with higher BMD, higher SMI, and lower fat %.
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5.1 Bone health in young adults with childhood-onset IBD
In study I of this thesis, we showed that young adults with childhood-onset IBD often 
had low aBMD in the lumbar spine at follow-up. Around one-third of the patients had 
lumbar spine aBMD Z-scores lower than -1. Further, one in ten patients had a very 
low lumbar spine aBMD Z-score below -2. To our knowledge, only two other smaller 
studies have reported aBMD measures in young adult patients with childhood-onset 
IBD. In accordance with our results, Laakso et al.33 reported low aBMD in about a 
third of young adults with childhood-onset IBD. Further, Guz-Mark et al.32 reported 
half of the young adults to have low aBMD, possibly overestimating the proportion 
due to a retrospective study design and selection bias. In contrast, studies involving 
middle-aged adult patients with IBD have reported a reduced prevalence of low 
aBMD, in around a fifth of adults with IBD67, 68. Our research group has previously 
published aBMD measurements in childhood and adolescence for this cohort10, 
11. Around half of the children with IBD had aBMD Z-scores lower than -1 and a 
quarter of patients lower than -210. However, our previous data indicated also that 
there could be a potential in these patients to increase their lumbar spine aBMD after 
having reached 18 years of age11.
In this thesis, we aimed to evaluate whether young adult patients with childhood-
onset IBD may have the potential to improve BMD beyond the expected age of 
PBM. We found that in total 17 patients in our cohort had reached the age for PBM 
attainment at the first follow-up, around six years before the current second follow-
up. Time for PBM attainment in a healthy population was based on Baxter-Jones et 
al. that found PBM to be achieved in the lumbar spine and hip five years after PHV7. 
In those 17 patients, supposedly having achieved PBM according to this estimation, 
we observed an increase of aBMD in both the lumbar spine (both genders) and total 
hip (females only) at the second follow-up. To conclude, this continued increase of 
BMD may indicate a window for BMD development of the lumbar spine beyond 
what is expected in the normal population.
In the group as a whole, we observed that the patients with childhood-onset IBD 
improved their lumbar spine aBMD Z-scores now in early adulthood compared to the 
previous first follow-up. These findings contrasted with Laakso et al.33 who reported 
no such improvement when patients were followed-up into early adulthood.
The most pronounced aBMD deficits in patients with IBD were found in the lumbar 
spine. These deficits might be explained by the fact that the lumbar spine is mainly 
comprised of trabecular bone36. Due to its high bone turnover, trabecular bone is 
sensitive to harmful factors, such as inflammation per se and corticosteroids37, both 
common in patients with IBD.
Advanced bone measurement techniques, such as HR-pQCT, are able to deepen 
the knowledge of the nature of bone deficits in patients with IBD but DXA is still 
the golden standard in the clinical setting. Using an HR-pQCT scan of the tibia, we 
found that both the cortical and trabecular microstructures were altered in young 
men with childhood-onset IBD compared to controls, even after adjusting for SMI 
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and physical exercise. To the best of our knowledge, only two HR-pQCT studies 
in patients with IBD have been published. In contrast to our study IV, Pepe et al.60 
reported a deficiency only in trabecular structures in children and young adults aged 
between 12 and 33 years of age (average age at diagnosis 17.3 years), some of them 
with childhood-onset IBD. Furthermore, Haschka et al.61 found that only cortical 
structure deficits were associated with IBD in older adult patients (median age 44 
years).
Our findings of deficits in both trabecular and cortical bone are in line with previous 
reports from children with IBD utilizing an older model of pQCT. This older model 
measures vBMD in trabecular and cortical bone separately without the ability to 
assess any microstructures. In several of these studies, both cortical and trabecular 
vBMD were lower in children with IBD than in controls55, 58, 59. To conclude, young 
adults with childhood-onset IBD run a high risk of compromised microstructures in 
both trabecular and cortical bone.
 
5.2 Body composition in young adults with childhood-
onset IBD. 
The evaluation of body composition traits, SMI and fat %, was performed in male 
and female patients separately. However, to interpret skeletal muscle and body fat 
together in all patients, we modified a model initially proposed by Baumgartner 
et al.79 to investigate body composition in the elderly. Such a model has, to our 
knowledge, not been previously used in patients with IBD. By combining SMI and 
fat percentage from a DXA scan, we defined four body composition profiles: i) 
normal, ii) myopenic, iii) obese, iv) myopenic-obese.
Our results show that a larger proportion of patients with IBD had alterations in 
body composition than controls. About a third of the patients had myopenia (low 
skeletal muscle mass) compared to around a fifth of the controls. Further, a fourth of 
the patients with IBD had obesity compared to less than a fifth of controls. Further, 
10% of the patients exhibited a myopenic-obese profile compared to only 2% of the 
controls. The use of SMI to estimate skeletal muscle mass has also been used by 
Bryant et al.111. In contrast to our findings, they reported myopenia only in about a 
fifth of adult patients with IBD (median age of 33 years). However, our patient cohort 
appears to have a longer disease duration as well as disease onset during childhood, 
possibly explaining this discrepancy as long-standing inflammation is associated with 
skeletal muscle defects89.
Our findings of a high prevalence of myopenia in early adulthood concern as an 
age-related decline of skeletal muscle mass occurs later in adulthood112. We also 
found that patients with myopenia had lower grip strength than patients without 
myopenia, indicating a possible risk for developing sarcopenia (a combination of 
low muscle strength and muscle mass) later in adulthood. In the elderly, sarcopenia 
is associated with increased risk for falls and fractures113, lower quality of life114, 
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mobility disorders115, and mortality116. Thus, suffering from myopenia already in 
early adulthood could imply a higher risk for severe consequences later in life. 
Previous studies, focusing on body composition measured with DXA in patients with 
IBD, have reported findings of total body lean mass deficiencies in both children82, 117 
and adults85, 86. Even though total body lean mass does not estimate skeletal muscle 
mass as accurately as SMI74, those previous studies support our findings that patients 
with IBD are at risk of developing skeletal muscle deficits. 
About a quarter of our patients was found to have obesity as part of their body 
composition profile, which was significantly more frequent than in controls. Previous 
studies have shown divergent results reporting either high or low fat mass in adult 
patients with IBD85, 117, 118. Previous studies of body composition vary greatly in 
design and cohort selection. Adjustments for age, weight, and gender must be 
considered when assessing fat mass85. Studies that focus on the impact of obesity 
in IBD have used high BMI as a marker for obesity. Although BMI is less accurate 
in estimating fat mass in patients with IBD than DXA scan81, 119, it is more readily 
available and widely used. High BMI (overweight and obesity) in patients with IBD 
has been, besides well-known risk factors of obesity120, associated with early surgical 
intervention in patients with Crohn’s disease121, more perioperative complications122, 
increased need for colectomy in patients with ulcerative colitis123 and predicted the 
need for dose escalation with adalimumab in patients with Crohn’s disease124. To 
conclude, our results indicate a high prevalence of obesity in young adults with IBD. 
A myopenic-obese profile was found significantly more often in patients with IBD 
than controls. This profile may combine the risks of myopenia as well as obesity. 
Furthermore, a myopenic-obese body composition profile has been linked to an 
increased risk for cardiometabolic syndrome125 and rapid loss of physical functions 
in late adulthood126. Notably, this group of patients had BMI similar to those with 
a normal body composition profile, thus, supporting the view that the traditional 
BMI to estimate body composition in patients with IBD is often inaccurate81, 119. 
This particular body composition profile had not been described in patients with 
IBD previously. Interestingly, Alsufyani et al. recently adopted our model in a study 
of Saudi Arabian children with IBD and reported, in line with our results, a high 
proportion of either myopenic or obese profile compared to controls84. However, in 
contrast to our findings in young adult patients, they did not report the myopenic-
obese body composition profile to be more prevalent in children with IBD than 
in controls. Further studies are needed to determine the development of body 
composition profiles from childhood throughout adulthood.
Both the myopenic and myopenic-obese profiles were associated with low aBMD, 
thus, as expected, the SMI Z-score was found to be independently associated with 
lower aBMD. Similarly, Bryant et al.111 also reported associations between low SMI 
and low BMD in adult patients with IBD. Such an association between myopenia 
and low aBMD has also been reported in healthy European men127. Skeletal muscle 
index estimates skeletal muscle mass more accurately than total body lean mass74 
and correlates more strongly to aBMD77. Therefore, we would suggest that SMI may 
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be used in future research on body composition and BMD instead of total body lean 
mass. However, the variation in SMI did not explain all the aBMD deficits in our 
group of patients with IBD as a diagnosis of IBD was independently associated with 
low aBMD.
In young adulthood, patients with the obese body composition profile appeared to 
have normal aBMD. However, fat % was not independently associated with changes 
in aBMD. This finding was somewhat unexpected as it is well known that increased 
weight is associated with denser bones in healthy adults128 and that fat mass per se is 
associated with higher aBMD in healthy adults78.
The patient group with myopenic-obese profile appeared to have the longest disease 
duration and earliest disease-onset of the profile groups. Thus, this body composition 
profile might result from a cumulative inflammatory burden, in line with findings 
in older adults, where chronic systemic inflammation has been associated with 
low skeletal muscle mass and high fat percentage129. In addition to inflammation, 
several other factors may influence body composition traits (Figure 5): Physical 
exercise promotes skeletal muscle gains130 and reduces fat131; nutritional status can 
be associated with low muscle mass88, 132 and obesity133; the use of corticosteroids is 
associated with higher fat mass92.
 
5.3 Physical exercise
We examined physical exercise habits in young adults and about 60% reported 
some form of regular physical exercise during the last year. The patient groups’ 
sport participation tended to be lower than that of controls (70%), although the 
difference did not reach statistical significance. Similar to our results, it seems that 
both children95 and adults97 with IBD tend to exercise less than controls. Regrettably, 
physical exercise is rarely discussed in the clinical setting134, only in about one-third 
of cases. In general, training is well tolerated135 and has been shown to increase the 
quality of life136 and reduce disease flares137. However, during active disease flares, 
intensive training is cautioned138.
The relationship between the amount of physical exercise and body composition 
has not been studied previously in young adult patients with childhood-onset IBD. 
In this thesis, all patients and controls were divided separately into three physical 
exercise subgroups based on their regular physical exercise: i) sedentary, ii) less than 
four hours of exercise per week, and iii) more than four hours of physical exercise 
weekly. We found increasing amounts of physical exercise to be associated with 
higher aBMD, higher SMI, and lower fat % in these young adult patients with IBD, 
especially in those with four or more hours of exercise per week. This patient group 
had aBMD and body composition traits in the same range as the control cohort 
average. These findings support the view that physical exercise could be a powerful 
tool to counteract alterations in aBMD and body composition102. Physical exercise 
can strengthen the bone by activating the muscle-bone unit101 and with activities such 
as jumping, directly affecting the skeleton99. We also found a similar association with 
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BMD, thus, physical exercise was independently associated with higher aBMD in 
the femoral neck after adjusting for SMI. Further, we showed that a diagnosis of IBD 
was independently associated with low aBMD after adjustments for SMI and amount 
of physical exercise. 
Interestingly, young adult patients that had regular physical exercise were more 
likely to have participated in sports during late adolescence than those patients that 
were sedentary. Suggesting that exercise habits of patients with IBD in childhood 
and adolescence may be associated with physical exercise engagement in adulthood. 
This relationship has been found in healthy individuals107 and physical exercise 
in childhood and adolescence has further been associated with bone health in 
adulthood139. 
 
5.4 Gender differences 
The group of young adult male patients had lower aBMD Z-scores than controls, 
whereas female patients did not show any differences. There are conflicting results 
regarding corresponding gender variation in children with IBD and most studies have 
not found any difference62, 65. However, our research group10, 11 had previously found 
that male gender was possibly associated with lower aBMD in a pediatric cohort 
of patients with IBD. Further, Gokhale et al.64 found pubertal and postpubertal girls 
with IBD in the United States to be more likely to have low aBMD than boys with 
IBD. Studies in adult patients with IBD have suggested that there might be an unmet 
need for vigilance for low BMD in male patients with IBD69, 140. Despite this need, 
low BMD and osteoporosis are important subjects for women in general, especially 
postmenopausal women who are at risk141 and this also applies to women with IBD71, 
142.
The exact reason for the BMD gender difference in our cohort is unclear as many 
factors affect bone mineralization. However, we found no indication that age at 
disease-onset, disease duration, and/or received medical/surgical therapy differed 
between men and women in young adulthood. Body composition traits in both men 
and women with IBD were similar to corresponding controls, although women with 
IBD had a higher fat % Z-score than men. However, we observed no gender-related 
differences in physical exercise habits.
A possible reason why young men with childhood-onset IBD are at greater risk of 
developing low BMD than young women may be that most of the bone mass is 
achieved during adolescence7 and/or different factors influence bone mineralization 
in males and females143. In healthy male adolescents, bone mass development is 
primarily dependent on the growth of the muscle-bone unit. This muscle-bone unit is 
susceptible to inflammation, lack of physical exercise, and nutritional deficits143. In 
contrast to males, bone mass accrual in female adolescents is less dependent on the 
interplay between muscle and bone but more dependent on estrogen143. Thus, it may 
be an actual gender difference as the impact of IBD possibly affects the muscle-bone 
unit more in males than in females during childhood.
Young adults with childhood-onset inflammatory bowel disease  
46 47
5.5 Crohn’s disease vs. ulcerative colitis
In this thesis, we found no apparent difference regarding BMD in patients with 
Crohn’s disease compared to those with ulcerative colitis. There are conflicting 
results in the literature on whether there is a difference in BMD between the IBD 
subcategories. Several studies found aBMD to be lower in patients with Crohn’s 
disease than patients with ulcerative colitis, both in childhood64, 66, and adulthood68, 71, 
144, whereas others, in line with our previous and current findings10, 11, did not find any 
difference33, 67, 69.
Skeletal muscle mass did not differ between patients with Crohn’s disease and 
ulcerative colitis (men and women combined). In line with our findings, SMI is 
reported to be similarly low, regardless of disease subcategory, in both children84 
and adult patients111 with IBD. However, in the current project, male patients with 
Crohn’s disease had a lower SMI Z-score than controls, whereas male patients with 
ulcerative colitis did not differ from controls. This difference might result from the 
disease being more active during childhood and adolescence in those with Crohn’s 
disease, possibly affecting the muscle-bone unit to a greater extent143. Regrettably, 
other studies focusing on SMI did not stratify by gender when comparing IBD 
subcategories84, 111. The use of SMI in studies of body composition in IBD is 
relatively new and previous studies have instead used total body lean mass85. Similar 
to our findings that SMI is more compromised in patients with Crohn’s disease, 
Bryant et al. published a systematic review of 19 studies on body composition in 
adults with IBD. A total of 28% of patients with Crohn’s disease and 13% of patients 
with ulcerative colitis were found to have low lean mass.
Fat percentage was in the same range in young adults with Crohn’s disease and those 
with ulcerative colitis. Interestingly, by taking both fat % and SMI into account and 
defining body composition profiles, we found that patients with ulcerative colitis 
were overrepresented in the obese body composition profile. Fourteen patients with 
ulcerative colitis (21%) and one patient with Crohn’s disease (3%) had high fat % 
without skeletal muscle mass deficits. Similar to our results, Bryant et al.85 recently 
reported that the prevalence of increased fat mass in adult patients with Crohn’s 
disease was 3%. However, the corresponding figure in patients with ulcerative colitis 
was 12%, a lower figure than we have found.
In study III, we found that patients with Crohn’s disease and those with ulcerative 
colitis reported that they were engaged in regular physical exercise to about the same 
extent. Between 50–60% of the young adults with childhood-onset IBD exercised 
regularly, so it is unlikely that subcategory differences in body composition are 
associated with physical exercise habits.
Our opinion is that our patient cohort of young adults with IBD in this second follow-
up represents the whole clinical spectrum of childhood-onset IBD. The cohort was 
population-based at baseline10 and participants did not differ from non-participants 
with regard to DXA measurements or clinical characteristics at the previous first 
follow-up (Table 1). 
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In summary, young adults with Crohn’s disease and those with ulcerative colitis 
have similar aBMD. Skeletal muscle mass deficits are prominent in male patients 
with Crohn’s disease. High fat percentage (obesity) appears to be more common in 
patients with ulcerative colitis than those with Crohn’s disease, regardless of gender.
 
5.6 Clinical implications
• Young adults with childhood-onset IBD showed alterations in both BMD and 
body composition. There is a need for preventive and therapeutic measures for 
patients with IBD as these alterations are potentially associated with morbidity 
later in adulthood.
• It would be of clinical value if all DXA scans included interpretation of body 
composition measurements such as SMI and fat %, in addition to estimation 
of aBMD. Currently, reference data are lacking for children. For young adults, 
threshold values from this thesis (study II) are available.
• Physical exercise appears to be important for counteracting BMD deficits and 
alterations in body composition traits. In our opinion, physical exercise should 
be routinely addressed in the clinical setting. A physical therapist may play an 
essential role in the multidisciplinary IBD team.
• Normal body composition traits might be a valuable surrogate marker for 
effective treatment and remission. Conversely could altered body composition 
serve as a red flag for incomplete disease control. 
• In the transition from pediatric to adult care of IBD, it may be of importance 
to highlight BMD deficits and lifestyle factors such as physical exercise, not 
least because of that the development of BMD seems to continue into young 
adulthood. 




6 Main conclusions 
• Young adults, especially men with childhood-onset IBD, are at risk for 
low aBMD and those young men also show widespread deficits in bone 
microstructures.
• Young adult female patients with childhood-onset IBD have similar aBMD 
compared to age- and gender-matched controls.
• Both male and female patients with childhood-onset IBD appear to improve 
their aBMD beyond the expected age for PBM.
• Young adults with childhood-onset IBD have a risk for altered body 
composition traits (myopenic, obese, and myopenic-obese profile) compared to 
controls.
• Young adult men with Crohn’s disease have an especially high risk for 
myopenia.
• Regular physical exercise in young adulthood may help to counteract the 
detrimental effects of IBD on BMD and body composition traits
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(Britt-Marie Käck), who managed all exchange of material used for creations at the 
Forge. Thank you.
Supplying the students at the Forge with exquisite material is a great challenge. 
However, the mineral experts Ulrika Hjertonsson and Vera Gligoric, in Grand 
Master Lorentzons clan, showed great prowess and lived up to the legendary status. 
Thank you.
After years of absence from the front lines, I give my deepest regards to my 
comrades in the pediatric gastroenterology regiment of her majesties, Queen 
Silvia’s royal army, for holding down the fort so impressively. I can only hope that 
we will continue our advance after my return, armed with new creations from master 
Saalman’s Forge of Science.
Finally, I could not have survived this journey without the support of my wife, 
Ingibjörg Sigurðardóttir. Who always radiates positivity and inspires me to 
greatness. Being a gifted illustration mage, she has given my creations true esthetic 
value. Ingibjörg, from the bottom of my heart, thank you.
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